InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Thursday, 05/18/2017 2:10:43 PM

Thursday, May 18, 2017 2:10:43 PM

Post# of 48316
Maxim has reiterated their buy on Oncosec with a $5 price target.....but they are lowballing their estimates which may have something to do with price drop. They are estimating 2021 approval with a $50 million annual revenue. Previous estimates were conservative at around $200 or $300 million (may be another analyst estimate other than Maxim). I think Oncosec gets fast track approval and sees more than $50 million in revenue potential.